CERO THERAPEUTICS HOLDINGS, INC. (CERO) Current Ratio
- Current ratio · latest quarter: Value 0.05×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.05× | Current assets / current liabilities. $1.55M ÷ $32.41M ≈ 0.05× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 1.55M USD | Assets, Current |
| Current obligations | 32.41M USD | Liabilities, Current |
| Cash and equivalents | 862.76K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 8.22M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.55M | $32.41M | $862.76K | (m) | (m) | (m) | $8.22M | (m) | 0.05× |
| 2026-03-31 | $1.57M | $11.33M | (m) | (m) | (m) | (m) | $7.69M | (m) | 0.14× |
| 2025-12-31 | $2.73M | $9.09M | (m) | (m) | (m) | (m) | $7.58M | (m) | 0.30× |
| 2025-09-30 | $2.55M | $8.45M | $1.90M | (m) | (m) | (m) | $7.08M | (m) | 0.30× |
| 2025-06-30 | $4.25M | $7.62M | $3.20M | (m) | (m) | (m) | $6.21M | (m) | 0.56× |
| 2025-03-31 | $5.77M | $7.86M | $5.10M | (m) | (m) | (m) | $6.38M | (m) | 0.73× |
| 2024-12-31 | $3.71M | $7.40M | (m) | (m) | (m) | (m) | $4.51M | (m) | 0.50× |
| 2024-09-30 | $3.71M | $9.42M | (m) | (m) | (m) | (m) | $6.67M | (m) | 0.39× |
| 2024-06-30 | $4.25M | $8.78M | (m) | (m) | (m) | (m) | $6.35M | (m) | 0.48× |
| 2024-03-31 | $5.50M | $11.65M | (m) | (m) | (m) | (m) | $7.06M | (m) | 0.47× |
| 2023-12-31 | $1.97M | $3.51M | (m) | (m) | (m) | (m) | $1.67M | (m) | 0.56× |
| 2022-09-30 | $785.29K | $875.97K | (m) | (m) | (m) | (m) | $710.36K | (m) | 0.90× |
| 2022-06-30 | $846.02K | $234.21K | (m) | (m) | (m) | (m) | $163.00K | (m) | 3.61× |
| 2022-03-31 | $1.10M | $174.66K | (m) | (m) | (m) | (m) | $121.34K | (m) | 6.28× |
| 2021-12-31 | $1.36M | $98.07K | $1.10M | (m) | (m) | (m) | (m) | (m) | 13.88× |
| 2021-09-30 | $24.00K | $277.00K | $0.00 | (m) | (m) | (m) | (m) | (m) | 0.09× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |